Follow the 동국생명과학 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 동국생명과학 has recorded 1 reports. Market capitalisation: €76.1bn. The latest transaction was reported on 9 April 2026 (Purchase). Among the most active insiders: 김영선. Every trade is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Dongguk Life Science es una empresa especializada en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se centra en el desarrollo y la fabricación de productos biofarmacéuticos.